Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment

K. Lukács, E. Berényi, M. Kávai, Gy Szegedi, M. Szekerke

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In vitro pre-incubation of monocytes derived from patients with Hodgkin's disease with tuftsin (50 μg/ml) significantly restored the deficient chemotactic responsiveness of these cells to the complement-derived factor C5a, as demonstrated by a monocyte migration assay based on the Boyden technique. Potentiation of the chemotactic responsiveness of monocytes was most significant after elective splenectomy. The results indicate that the specific receptors required for tuftsin activities may be available on the monocyte membranes in Hodgkin's disease. Since tuftsin is a natural, non-immunogenic tetrapeptide that can also be produced synthetically, it may provide a new therapeutic approach in Hodgkin's disease to at least partial restoration of the defective cellular immunity.

Original languageEnglish
Pages (from-to)162-163
Number of pages2
JournalCancer Immunology Immunotherapy
Volume15
Issue number2
DOIs
Publication statusPublished - Jul 1983

Fingerprint

Tuftsin
Chemotaxis
Hodgkin Disease
Monocytes
Splenectomy
Therapeutics
Cellular Immunity
Membranes
In Vitro Techniques

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment. / Lukács, K.; Berényi, E.; Kávai, M.; Szegedi, Gy; Szekerke, M.

In: Cancer Immunology Immunotherapy, Vol. 15, No. 2, 07.1983, p. 162-163.

Research output: Contribution to journalArticle

Lukács, K. ; Berényi, E. ; Kávai, M. ; Szegedi, Gy ; Szekerke, M. / Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment. In: Cancer Immunology Immunotherapy. 1983 ; Vol. 15, No. 2. pp. 162-163.
@article{b4f4c34255694e2eac37c58fb1d8c78b,
title = "Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment",
abstract = "In vitro pre-incubation of monocytes derived from patients with Hodgkin's disease with tuftsin (50 μg/ml) significantly restored the deficient chemotactic responsiveness of these cells to the complement-derived factor C5a, as demonstrated by a monocyte migration assay based on the Boyden technique. Potentiation of the chemotactic responsiveness of monocytes was most significant after elective splenectomy. The results indicate that the specific receptors required for tuftsin activities may be available on the monocyte membranes in Hodgkin's disease. Since tuftsin is a natural, non-immunogenic tetrapeptide that can also be produced synthetically, it may provide a new therapeutic approach in Hodgkin's disease to at least partial restoration of the defective cellular immunity.",
author = "K. Luk{\'a}cs and E. Ber{\'e}nyi and M. K{\'a}vai and Gy Szegedi and M. Szekerke",
year = "1983",
month = "7",
doi = "10.1007/BF00199710",
language = "English",
volume = "15",
pages = "162--163",
journal = "Cancer Immunology, Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "2",

}

TY - JOUR

T1 - Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment

AU - Lukács, K.

AU - Berényi, E.

AU - Kávai, M.

AU - Szegedi, Gy

AU - Szekerke, M.

PY - 1983/7

Y1 - 1983/7

N2 - In vitro pre-incubation of monocytes derived from patients with Hodgkin's disease with tuftsin (50 μg/ml) significantly restored the deficient chemotactic responsiveness of these cells to the complement-derived factor C5a, as demonstrated by a monocyte migration assay based on the Boyden technique. Potentiation of the chemotactic responsiveness of monocytes was most significant after elective splenectomy. The results indicate that the specific receptors required for tuftsin activities may be available on the monocyte membranes in Hodgkin's disease. Since tuftsin is a natural, non-immunogenic tetrapeptide that can also be produced synthetically, it may provide a new therapeutic approach in Hodgkin's disease to at least partial restoration of the defective cellular immunity.

AB - In vitro pre-incubation of monocytes derived from patients with Hodgkin's disease with tuftsin (50 μg/ml) significantly restored the deficient chemotactic responsiveness of these cells to the complement-derived factor C5a, as demonstrated by a monocyte migration assay based on the Boyden technique. Potentiation of the chemotactic responsiveness of monocytes was most significant after elective splenectomy. The results indicate that the specific receptors required for tuftsin activities may be available on the monocyte membranes in Hodgkin's disease. Since tuftsin is a natural, non-immunogenic tetrapeptide that can also be produced synthetically, it may provide a new therapeutic approach in Hodgkin's disease to at least partial restoration of the defective cellular immunity.

UR - http://www.scopus.com/inward/record.url?scp=0020574152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020574152&partnerID=8YFLogxK

U2 - 10.1007/BF00199710

DO - 10.1007/BF00199710

M3 - Article

C2 - 6553514

AN - SCOPUS:0020574152

VL - 15

SP - 162

EP - 163

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

SN - 0340-7004

IS - 2

ER -